MLXIPL and Hepatic fibrosis: We found that AESN elevated PPARα and PGC-1α mRNA levels in HFD/ethanol-induced rats, and inhibited the decrease in ACC, FAS, and ChREBP mRNA levels (Figure 6), thereby improving hyerlipidemia (Table 1) and suppress HSCs activation and hepatic fibrosis.